Related Experiment Video
Updated: Jul 12, 2025
10:16
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
3.3K
In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
Alexey D Perenkov1, Alena D Sergeeva1, Maria V Vedunova1
1Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, 603022 Nizhny Novgorod, Russia.
Vaccines
|October 28, 2023
Summary
Messenger RNA (mRNA) vaccines, including newer self-amplifying mRNA, trans-amplifying mRNA, and circular RNA platforms, offer promising advancements for developing effective vaccines against viral diseases and cancer.
Area of Science:
- Molecular Biology
- Vaccinology
- Biotechnology
Background:
- Messenger RNA (mRNA) was discovered in 1961, with its vaccine application emerging decades later.
- The COVID-19 pandemic significantly accelerated the development of mRNA vaccine technology.
- Enhancements like self-amplifying mRNA (saRNA) and trans-amplifying mRNA (taRNA) were developed to improve RNA vaccine properties, particularly circulation time.
Purpose of the Study:
- To provide an overview of the foundational mRNA platform.
- To critically discuss advanced mRNA-based platforms: saRNA, taRNA, and circular RNA (circRNA).
- To compare the features, advantages, and disadvantages of these RNA vaccine technologies.
Main Methods:
- Literature review of mRNA vaccine technology.
- Comparative analysis of different mRNA-based platforms (mRNA, saRNA, taRNA, circRNA).
- Discussion of platform characteristics relevant to vaccine development.
Main Results:
- mRNA vaccine technology has evolved significantly since its inception.
- saRNA, taRNA, and circRNA platforms present distinct advantages over traditional mRNA.
- circRNA and taRNA are identified as particularly promising vaccine platforms.
Conclusions:
- Advanced mRNA platforms like saRNA, taRNA, and circRNA offer improved properties for vaccine development.
- Each platform has unique features, benefits, and drawbacks.
- This comparative analysis aids in selecting optimal RNA platforms for cancer and viral disease vaccines.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
01:29Viruses with RNA Genomes
35
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
35
02:28Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K